BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10936788)

  • 1. Pre-existing histological type and developmental mechanism of mucinous noncystic carcinoma of pancreas.
    Suda K; Nobukawa B; Yamasaki S; Suzuki F; Shimizu H; Takase M
    Pathol Oncol Res; 2000; 6(2):125-9. PubMed ID: 10936788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma.
    Lüttges J; Zamboni G; Longnecker D; Klöppel G
    Am J Surg Pathol; 2001 Jul; 25(7):942-8. PubMed ID: 11420467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MUC1 overexpression is the most reliable marker of invasive carcinoma in intraductal papillary-mucinous tumor (IPMT).
    Ueda M; Miura Y; Kunihiro O; Ishikawa T; Ichikawa Y; Endo I; Sekido H; Togo S; Shimada H
    Hepatogastroenterology; 2005; 52(62):398-403. PubMed ID: 15816444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease spectrum of intraductal papillary mucinous neoplasm with an associated invasive carcinoma invasive IPMN versus pancreatic ductal adenocarcinoma-associated IPMN.
    Kang MJ; Lee KB; Jang JY; Kwon W; Park JW; Chang YR; Kim SW
    Pancreas; 2013 Nov; 42(8):1267-74. PubMed ID: 24308063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms.
    Nara S; Shimada K; Kosuge T; Kanai Y; Hiraoka N
    Am J Surg Pathol; 2008 Feb; 32(2):243-55. PubMed ID: 18223327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stromal thrombospondin-1 expression is a prognostic indicator and a new marker of invasiveness in intraductal papillary-mucinous neoplasm of the pancreas.
    Okada K; Hirabayashi K; Imaizumi T; Matsuyama M; Yazawa N; Dowaki S; Tobita K; Ohtani Y; Tanaka M; Inokuchi S; Makuuchi H
    Biomed Res; 2010 Feb; 31(1):13-9. PubMed ID: 20203415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive carcinoma derived from intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic and immunohistochemical study of eight cases.
    Fukushima N; Mukai K; Sakamoto M; Hasebe T; Shimada K; Kosuge T; Kinoshita T; Hirohashi S
    Virchows Arch; 2001 Jul; 439(1):6-13. PubMed ID: 11499841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraductal tubular neoplasms of the pancreas: histogenesis and differentiation.
    Tajiri T; Tate G; Inagaki T; Kunimura T; Inoue K; Mitsuya T; Yoshiba M; Morohoshi T
    Pancreas; 2005 Mar; 30(2):115-21. PubMed ID: 15714133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic and immunohistochemical comparison of intraductal tubular carcinoma, intraductal papillary-mucinous carcinoma, and ductal adenocarcinoma of the pancreas.
    Tajiri T; Tate G; Kunimura T; Inoue K; Mitsuya T; Yoshiba M; Morohosh T
    Pancreas; 2004 Aug; 29(2):116-22. PubMed ID: 15257103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcellular localization of KL-6 mucin in intraductal papillary mucinous neoplasm of the pancreas.
    Inagaki Y; Seyama Y; Hasegawa K; Tang W; Kokudo N
    Drug Discov Ther; 2014 Aug; 8(4):173-7. PubMed ID: 25047009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucinous carcinomas of the gallbladder: clinicopathologic analysis of 15 cases identified in 606 carcinomas.
    Dursun N; Escalona OT; Roa JC; Basturk O; Bagci P; Cakir A; Cheng J; Sarmiento J; Losada H; Kong SY; Ducato L; Goodman M; Adsay NV
    Arch Pathol Lab Med; 2012 Nov; 136(11):1347-58. PubMed ID: 23106580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
    Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
    Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an "intestinal" pathway of carcinogenesis in the pancreas.
    Adsay NV; Merati K; Basturk O; Iacobuzio-Donahue C; Levi E; Cheng JD; Sarkar FH; Hruban RH; Klimstra DS
    Am J Surg Pathol; 2004 Jul; 28(7):839-48. PubMed ID: 15223952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative evaluation of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas: clinical, radiological, and pathological analysis of 123 cases.
    Nara S; Onaya H; Hiraoka N; Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T
    Pancreas; 2009 Jan; 38(1):8-16. PubMed ID: 18665010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions.
    Terris B; Dubois S; Buisine MP; Sauvanet A; Ruszniewski P; Aubert JP; Porchet N; Couvelard A; Degott C; Fléjou JF
    J Pathol; 2002 Aug; 197(5):632-7. PubMed ID: 12210083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colloid (mucinous noncystic) carcinoma of the pancreas.
    Adsay NV; Pierson C; Sarkar F; Abrams J; Weaver D; Conlon KC; Brennan MF; Klimstra DS
    Am J Surg Pathol; 2001 Jan; 25(1):26-42. PubMed ID: 11145249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive, mixed-type intraductal papillary mucinous neoplasm: superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm.
    Ceppa EP; Roch AM; Cioffi JL; Sharma N; Easler JJ; DeWitt JM; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
    Surgery; 2015 Oct; 158(4):937-44; discussion 944-5. PubMed ID: 26173683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma.
    Matsukita S; Nomoto M; Kitajima S; Tanaka S; Goto M; Irimura T; Kim YS; Sato E; Yonezawa S
    Histopathology; 2003 Jan; 42(1):26-36. PubMed ID: 12493022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the tumor suppressor gene maspin and its significance in intraductal papillary mucinous neoplasms of the pancreas.
    Kashima K; Ohike N; Mukai S; Sato M; Takahashi M; Morohoshi T
    Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):86-90. PubMed ID: 18234645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic mucinous noncystic (colloid) carcinomas and intraductal papillary mucinous carcinomas are usually microsatellite stable.
    Lüttges J; Beyser K; Pust S; Paulus A; Rüschoff J; Klöppel G
    Mod Pathol; 2003 Jun; 16(6):537-42. PubMed ID: 12808058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.